Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. - Wikidata - awgldk - TriplyDB

Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.

Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.

http://www.wikidata.org/entity/Q35049019

about

Cardiac purinergic signalling in health and disease Cardioprotection with adenosine: 'a riddle wrapped in a mystery'.Influence of cardiac nerve status on cardiovascular regulation and cardioprotection New insights into adenosine-mediated myocardial protection.Preoxygenated hemoglobin-based oxygen carrier HBOC-201 annihilates myocardial ischemia during brief coronary artery occlusion in pigs.Interaction between pre- and postconditioning in the in vivo rat heart.Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Centre de Résonance Magnétique Biologique et Médicale (CRMB) solution.Role of the autonomic nervous system in cardioprotection by remote preconditioning in isoflurane-anaesthetized dogs.Cardiac effects of postconditioning depend critically on the duration of index ischemia.

P2860

Q33165093-BABD5441-D4AD-4CFA-B696-E6FD817B1C66 Q36128227-B66FF785-DB60-4135-89EF-F7FD3D23DFE1 Q39434028-7B71E944-2316-4293-A701-986174622B16 Q42035654-99594113-3BEB-4781-9154-0718A56AE65D Q43198445-DA14BC08-A6E1-42F0-B4D2-A3A8AED8E512 Q43298105-7A7D8400-25CE-46B7-A754-2C0D63E42435 Q46881711-808EA770-9F8F-43AC-AF60-00A0E4B70E7D Q48324036-51325835-2E46-460E-B581-4A7F18D9C8BD Q51928304-CC19C26C-CE08-47FE-9441-87CABD093387

P2860

Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.

http://www.wikidata.org/entity/Q35049019

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@ast

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@en

type

label

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@ast

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@en

prefLabel

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@ast

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@en

P1433

Q35049019-C3D944FE-E90B-4A1B-9DE9-2A6A2C40B5E9

P1476

Q35049019-EA23D001-69B0-48B6-9874-D7FD3C46272B

P2093

Q35049019-489EFF26-4412-4DFA-A05D-54BE6C1F0216

Q35049019-560B36FD-409A-4BF5-96B6-7AF45CE733EC

Q35049019-5836D6F8-88E7-4E2A-A0C4-1254523B1723

Q35049019-7A545237-7447-4814-AB53-A5BAC3076BA5

Q35049019-E27BC250-C94B-4A1B-8A09-B08A11E863EB

P2860

Q35049019-005F9F24-6301-4167-8FBA-EDF556D5D5E7

Q35049019-00C2084C-FA44-49A7-86ED-140EF3E45A1C

Q35049019-02F06F7E-9C44-4A78-BD67-BA703E555F60

Q35049019-0864BCA4-6146-4D7B-ADA0-5787850FD84D

Q35049019-0BF84618-E256-4376-BF61-1F12EEEEDB01

Q35049019-0FB8FBC6-E61E-4CA5-BAEC-0B527E4F01BA

Q35049019-15CAF882-BE2F-43EF-9D3A-7FBEE7155A5F

Q35049019-194DCA3B-62EB-419F-9DCD-E37302448BB8

Q35049019-1FD44900-4C5D-4627-946E-F16A2F375C56

Q35049019-2B8A76D8-DF7B-4491-BD57-A3BA27371902

P304

Q35049019-BFBF2E5D-A082-4B34-A180-9F235A176AB1

P31

Q35049019-BEB93EA4-6F9D-4EAA-92DB-73AA16D54203

P356

Q35049019-5D19E9FC-3FDD-453E-A5CA-053C8303756A

P407

Q35049019-EEEAB727-E0FC-44D2-8E5C-B1B58B9702DA

P433

Q35049019-9572F915-2510-4E47-B721-DC46D92DD3A3

P478

Q35049019-D4F05A84-DADE-45E5-BDF3-9DA67386C190

P577

Q35049019-0190795B-7CEE-4182-A0D6-66CB52235BA9

P5875

Q35049019-FEE93941-4FFC-42F6-80BB-957B739760D2

P698

Q35049019-CC29E2B9-8EA4-420A-AA20-5681892918D1

P932

Q35049019-0159C5E4-439A-4955-A04B-6CAAE39E5EFE

P356

P1433

British Journal of Pharmacology

P1476

Intravenous adenosine protects ...... ation of a neurogenic pathway.

@en

P2093

Dirk J Duncker

http://www.w3.org/2001/XMLSchema#string

Elisabeth Keijzer

http://www.w3.org/2001/XMLSchema#string

Maaike te Lintel Hekkert

http://www.w3.org/2001/XMLSchema#string

Olivier C Manintveld

http://www.w3.org/2001/XMLSchema#string

Pieter D Verdouw

http://www.w3.org/2001/XMLSchema#string

P2860

Adenosine, adenosine receptors and myocardial protection: an updated overview

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.

Adenosine and preconditioning in the rat heart.

Myocardial protection by brief ischemia in noncardiac tissue.

Role of nitric oxide in adenosine-induced vasodilation in humans.

Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Adenosine in myocardial protection in on-pump and off-pump cardiac surgery.

Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning.

Acute adenosinergic cardioprotection in ischemic-reperfused hearts.

P304

703-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0706258

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7846520

http://www.w3.org/2001/XMLSchema#string

P698

15895104

http://www.w3.org/2001/XMLSchema#string

P932

1576200

http://www.w3.org/2001/XMLSchema#string